ADA Supports FDA Panel's Recommendation for Scientific Review

Dec 15, 2010, 20:26 ET from American Dental Association

WASHINGTON, Dec. 15, 2010 /PRNewswire-USNewswire/ -- The American Dental Association today praised a Food and Drug Administration advisory panel's finding that the FDA acted appropriately when it ruled last year that dental amalgam is a safe and effective treatment option for the general population.  

"The panel recommended continuing review of existing and new scientific information as it becomes available," said ADA President Raymond F. Gist, DDS.  "As a science-based organization representing a science-based profession, we support this."

"As with all clinical issues, our position on amalgam is based on the best available science.  We will continue to maintain or revise our positions on oral health and oral health care issues accordingly.  At the end of the day, all treatment decisions should be made by patients with the advice of their dentists.  We support the rights of all patients to decide how best to maintain and improve their oral health."

About the American Dental Association

The not-for-profit ADA is the nation's largest dental association, representing more than 157,000 dentist members. The premier source of oral health information, the ADA has advocated for the public's health and promoted the art and science of dentistry since 1859. The ADA's state-of-the-art research facilities develop and test dental products and materials that have advanced the practice of dentistry and made the patient experience more positive. The ADA Seal of Acceptance long has been a valuable and respected guide to consumer dental care products. The monthly Journal of the American Dental Association (JADA) is the ADA's flagship publication and the best-read scientific journal in dentistry. For more information about the ADA, visit the Association's Web site at

SOURCE American Dental Association